» Articles » PMID: 30871704

Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar

Overview
Date 2019 Mar 16
PMID 30871704
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Postural orthostatic tachycardia syndrome (POTS), the most common form of orthostatic intolerance in young people, affects approximately 500,000 people in the United States alone, typically young women at the peak of their education and the beginning of their working lives. This is a heterogeneous disorder, the pathophysiology and mechanisms of which are not well understood. There are multiple contributing factors and numerous potential mimics. This review details the most current views on the potential causes, comorbid conditions, proposed subtypes, differential diagnoses, evaluations, and treatment of POTS from cardiological and neurological perspectives.

Citing Articles

Carbidopa: beyond Parkinson's disease.

Lenka A, Vernino S Clin Auton Res. 2025; .

PMID: 40056295 DOI: 10.1007/s10286-025-01122-y.


Tragus Nerve Stimulation Attenuates Postural Orthostatic Tachycardia Syndrome in Post COVID-19 Infection.

Wang Z, Zhu T, Li X, Lai X, Chen M Clin Cardiol. 2025; 48(3):e70110.

PMID: 40014480 PMC: 11867165. DOI: 10.1002/clc.70110.


Outcomes of Pediatric Patients with Excessive Postural Tachycardia After Attending an Intensive Interdisciplinary Pain Program: A Pilot Study.

Harbeck-Weber C, Klaas K, Sim L, Weiss K, Shappell A, Harrison T Children (Basel). 2025; 12(2).

PMID: 40003288 PMC: 11853926. DOI: 10.3390/children12020186.


Exercise rehabilitation for people with postural tachycardia syndrome at two secondary care centres in the UK: the PULSE feasibility randomised controlled trial.

McGregor G, Evans B, Sandhu H, Bruce J, Devi G, Hayat S BMJ Open. 2025; 15(2):e090197.

PMID: 39987007 PMC: 11848665. DOI: 10.1136/bmjopen-2024-090197.


Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review of studies before and during the COVID-19 pandemic.

Pierson B, Apilado K, Franzos M, Allard R, Mancuso J, Tribble D Front Neurol. 2025; 15:1515486.

PMID: 39882369 PMC: 11775448. DOI: 10.3389/fneur.2024.1515486.